biotech / news / / Zee News
Bharat Biotech is considering an initial public offering that could raise over USD 500 million.
Bharat Biotech is considering an IPO to raise over USD 500 million, sources report.
KEY POINTS
- The company plans Rs 200–250 crore capex in FY26 for a Sapigen Biologix facility in Odisha.
- Bharat Biotech's operating profit margin rose to 28.2% in FY25 from 8.8% in FY24.
- Government and UNICEF contracts are key revenues but expose Bharat Biotech to tender-driven volatility.
- India's pharma sector saw $3.5 billion in deal value with 72 transactions in Q3 2025.
COMPANIES
Summarized by Newsio from Zee News. How we summarize →